Literature DB >> 7295012

[Clinical applications of visual evoked potentials for detection of chiasmal and postchiasmal lesions (author's transl)].

L M Camacho, W Wenzel, J Aschoff.   

Abstract

Visual evoked potentials (VEP) were recorded in 18 patients with pathologic processes confirmed by computerized tomography in the chiasmal (n = 9) and parietooccipital region (n = 9). Reactions from the right and left hemisphere could be recorded separately in spite of using a simple one-channel apparatus and electrodes only at Oz and Cz. In 17 cases changes of the VEP provided information concerning the localization and extension of the lesion. In chiasmal processes we found a prolongation of monocular latencies, and a delayed or extinguished reaction to half-field stimulation from temporal retinal areas. However, the VEP was often pathologic for half-field stimulation of the nasal hemiretina. Pathologic VEPs were not always accompanied by visual field defects. In contrary to patients with chiasmal processes no pathologic reaction could be found to full-field stimulation in parieto-occipital lesions. Only when the affected hemisphere was stimulated selectively were diminution of amplitudes, prolongation of latencies, or extinguished responses observed. The VEP changes were uniform despite the cause of the lesion (tumor, ischemia). In chiasmal and parieto-occipital processes the VEP supplements computerized tomography by detecting deficits in function. This method appears suitable for monitoring the course of disease before and after neurosurgery.

Entities:  

Mesh:

Year:  1981        PMID: 7295012     DOI: 10.1007/bf00344449

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr (1970)


  25 in total

1.  ALTERATIONS OF VISUAL EVOKED RESPONSE IN THE PRESENCE OF HOMONYMOUS VISUAL DEFECTS.

Authors:  H G VAUGHAN; R KATZMAN; J TAYLOR
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1963-10

2.  Diagnostic value of visual evoked response, clinical eye examination and CSF analysis in chronic myelopathy.

Authors:  H Bynke; J E Olsson; I Rosén
Journal:  Acta Neurol Scand       Date:  1977-07       Impact factor: 3.209

3.  Modifications of the pattern-evoked potential (PEP) in relation to the stimulated part of the visual field (clues for the most probable origin of each component).

Authors:  N Lesevre; J P Joseph
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1979-08

4.  Visual evoked responses in pernicious anemia.

Authors:  J Troncoso; E L Mancall; N J Schatz
Journal:  Arch Neurol       Date:  1979-03

5.  Field studies of averaged visually evoked EEG potentials in a patient with a split chiasm.

Authors:  D Lehmann; R N Kavanagh; D H Fender
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1969-02

6.  Visual evoked response in diagnosis of multiple sclerosis.

Authors:  A M Halliday; W I McDonald; J Mushin
Journal:  Br Med J       Date:  1973-12-15

7.  Proceedings: The visual evoked response in ophthalmology.

Authors:  G B Arden
Journal:  Proc R Soc Med       Date:  1973-10

8.  Localization of the human visual evoked response. Early components specific to visual stimulation.

Authors:  Z Nakamura; W R Biersdorf
Journal:  Am J Ophthalmol       Date:  1971-11       Impact factor: 5.258

9.  Changes in pattern-evoked responses in man associated with the vertical and horizontal meridians of the visual field.

Authors:  A M Halliday; W F Michael
Journal:  J Physiol       Date:  1970-06       Impact factor: 5.182

10.  [Chiasmatic syndrome--clinical value of the visual evoked responses (VER) to the diagnosis (author's transl)].

Authors:  S Korol
Journal:  Klin Monbl Augenheilkd       Date:  1977-02       Impact factor: 0.700

View more
  2 in total

1.  Visual evoked potentials in tumors from orbita to occipital lobe in childhood.

Authors:  D Wenzel; U Brandl; J D Beck; C Cedzich; F Albert
Journal:  Neurosurg Rev       Date:  1988       Impact factor: 3.042

2.  The electrophysiological tests in the early detection of the visual pathway dysfunction in patients with microadenoma.

Authors:  Ewelina Lachowicz; Wojciech Lubiński; Wojciech Gosławski; Elżbieta Andrysiak-Mamos; Agnieszka Kaźmierczyk-Puchalska; Anhelli Syrenicz
Journal:  Doc Ophthalmol       Date:  2021-03-20       Impact factor: 2.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.